Tech Company Financing Transactions
Phagenesis Funding Round
On 3/4/2024, Phagenesis raised $42 million in Series D funding from EQT Life Sciences, Sectoral Asset Management and Aphelion Capital.
Transaction Overview
Company Name
Announced On
3/4/2024
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series D
Investors
EQT Life Sciences (Lead Investor)
Sectoral Asset Management (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and development efforts. With the recent approval of Phagenyx® by the FDA in the United States, the investment is primarily intended to support commercialization in the United States and deepen penetration in Europe. It will also support clinical trials, regulatory activities, as well as research and development of pipeline products.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Unit 18 Enterprise House, Manchester Science Park
Manchester, M15 6SE
UK
Manchester, M15 6SE
UK
Phone
Website
Email Address
Overview
Phagenesis is committed to scientific and clinical excellence in the development of novel therapies to treat patients suffering from neurogenic dysphagia. The foundational science and clinical evidence for the pharyngeal electrical stimulation used in Phagenyx, has been peer reviewed and published at the highest level.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Reinhard Krickl
Chief Financial Officer
Tarja Barnes
Chief Operating Officer
Conor Mulrooney
Chief Scientific Officer
Shaheen Hamdy
Vice President
Scott Grant
VP - Human Resources
Claire Collins
VP - Marketing
Anil Keni
VP - Sales
Peter Lucks
Browse more venture capital transactions:
Prev: 3/3/2024: Moonhub venture capital transaction
Next: 3/4/2024: Toolify Robotics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs